Completed NA INTERVENTIONAL NCT04573595

Fresenius Noninvasive Blood Pressure Validation (BPM2)

Fresenius Noninvasive Blood Pressure Validation - Three Phase Study PR 2020-377

Sponsor: Fresenius Medical Care North America

Interventions Blood Pressure Measurement

Updated 5 times since 2020 Last updated: Feb 1, 2021 Started: Sep 17, 2020 Primary completion: Dec 4, 2020 Completion: Dec 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04573595, this NA trial focuses on Blood Pressure and remains completed. Sponsored by Fresenius Medical Care North America, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Mar 2021 [monthly]

Recruiting NA
Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Medical Care North America

Data source: Fresenius Medical Care North America

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States